Thalys Medical Technology Group (603716.SS) Stock Price

Thalys Medical Technology Group Price

CLOSED
14.79
​
Market closed

Revenue has compounded at 13.0% per year over the past 14 years to 1.08 B CNY. Earnings per share have grown at 4.3% per year over the last 9 years. Thalys Medical Technology Group's net margin stands at -19.2%, down from -1.9% several years earlier. Thalys Medical Technology Group currently offers a dividend yield of about 0.54%. The payout ratio is around 31% of earnings. The dividend has grown at 51.7% per year over the past 3 years.

Thalys Medical Technology Group stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Thalys Medical Technology Group business model & stock analysis

Thalys Medical Technology Group Corp, based in Wuhan, China, operates in the Health Care sector with a focus on Biotechnology. The company develops, produces, and sells in vitro diagnostic products, including reagents, consumables, and equipment. It serves major domestic markets such as Hubei, Hunan, Jiangsu, Henan, and Shanghai, employing 1,474 full-time staff. Listed on October 31, 2016, Thalys specializes in diagnostic solutions for the Chinese healthcare market.

Frequently asked questions about Thalys Medical Technology Group

5 analysts currently rate the Thalys Medical Technology Group stock: 4 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the Thalys Medical Technology Group share trades at 1.97 EUR (14.79 CNY).

The revenue cannot currently be calculated for Thalys Medical Technology Group.

The profit cannot currently be calculated for Thalys Medical Technology Group.

The P/E ratio cannot be calculated for Thalys Medical Technology Group at the moment.

The P/S cannot be calculated for Thalys Medical Technology Group currently.

The Eulerpool Quality Score for Thalys Medical Technology Group is 2/10.

The ISIN of Thalys Medical Technology Group is CNE1000030C3. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Thalys Medical Technology Group is 603716.SS. The ticker symbol is used to trade Thalys Medical Technology Group shares on the stock exchange.

Fair ValueTerminal
12.72 CNY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue per Employee
730,634.74 CNY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
CNY
Initial public offering
Oct 31, 2016
ISIN
CNE1000030C3
Cusip
Y9714W100
Market capitalization
2.84 B CNYMid Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
3.01
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-21.87 %
Dividend
Dividend yield
0.00 %
Est. Dividend Yield
0.65 %
Payout Ratio
21.87 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
0 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
10.00 %
Last updated Oct 22, 2026, 10:26 AM

Thalys Medical Technology Group Peer Group

Thalys Medical Technology Group FIGI

603716:CH · BBG006R148Q4603716:CG · BBG006R148S2